Frontiers in Cellular and Infection Microbiology · 2024 · 22 citations · 43 references
Life SciencesMedicinal ChemistryMolecular BiologyMolecular VirologyPlant Molecular BiologyPlant VirologyAntioxidant DefenseAntiviral AgentsAntiviral PharmacologyAntiviral TherapyMedicinal PlantsViral HepatitisAntioxidant PharmacologyAntioxidant PropertiesAntiviral TreatmentFlavonoid MetabolismFlavonoid-mediated InhibitionOxidative Stress InjuryViral Entry InhibitorsViral Replication Control
Flavonoids, a diverse group of polyphenolic compounds found in various plant-based foods, have garnered attention for their potential in combating Hepatitis B Virus (HBV) infection. Flavonoids have demonstrated promising anti-HBV activities by interfering with multiple stages of the HBV life cycle, making them promising candidates for novel antiviral agents. Certain plant families, such as Theaceae , Asteraceae , Lamiaceae , and Gentianaceae , are of particular interest for their flavonoid-rich members with anti-HBV activities. Evidences, both in vitro and in vivo , supports the anti-HBV potential of flavonoids. These subsets of compound exert their anti-HBV effects through various mechanisms, including inhibiting viral entry, disrupting viral replication, modulating transcription factors, enhancing the immune response, and inducing autophagy. The antioxidant properties of flavonoids play a crucial role in modulating oxidative stress associated with HBV infection. Several flavonoids like epigallocatechin gallate (EGCG), proanthocyanidin (PAC), hexamethoxyflavone, wogonin, and baicalin have shown significant anti-HBV potential, holding promise as therapeutic agents. Synergistic effects between flavonoids and existing antiviral therapies offer a promising approach to enhance antiviral efficacy and reduce drug resistance. Challenges, including limited bioavailability, translation from preclinical studies to clinical practice, and understanding precise targets, need to be addressed. Future research should focus on clinical trials, combination therapies, and the development of flavonoid derivatives with improved bioavailability, and optimizing their effectiveness in managing chronic HBV infections.
43
Anti-hepatitis B virus activity of wogonin in vitro and in vivo
Qinglong Guo, Li Zhao, Qidong You et al. · Antiviral Research · 2007 · 182 citations
Polyphenols in Health and Disease: Gut Microbiota, Bioaccessibility, and Bioavailability
Joaquim Bié, Bruno Sepodes, Pedro Fernandes et al. · Compounds · 2023 · 174 citations · Full text
(−)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes
Hsiu‐Chen Huang, Mi‐Hua Tao, Tzu‐Min Hung et al. · Antiviral Research · 2014 · 151 citations